CJC-1295 (No DAC)
Reported Onset
2–4 weeks
Primary Use
Pulsatile GH release that mimics natural GH secretion patterns.
Dose
100mcg - 200mcg
Frequency
2-3x daily (with Ipamorelin)
CJC-1295 with DAC
Reported Onset
2–4 weeks
Primary Use
Sustained GH elevation with less frequent dosing.
Dose
1mg - 2mg
Frequency
1-2x weekly
Community Verdict
Most searched GHRH comparison — DAC vs No DAC is a fundamental protocol decision. The community generally selects between CJC-1295 (No DAC) and CJC-1295 with DAC based on their specific goals and experience. Both compounds are available through physician-supervised protocols at Alukard, where a physician can help determine which is most appropriate for your situation.
Get a Physician-Supervised Protocol for CJC-1295 (No DAC) or CJC-1295 with DAC at Alukard
Community experiences are a starting point — but a physician-supervised protocol from Alukard gives you pharmaceutical-grade compounds, proper dosing, lab monitoring, and the safety of medical oversight.
MD
Supervised
GMP
Certified
Labs
Monitoring
COA
Verified